Literature DB >> 8058617

A simple and rapid fluorometric determination method of alpha 1-acid glycoprotein in serum using quinaldine red.

H Imamura1, T Maruyama, H Okabe, H Shimada, M Otagiri.   

Abstract

We examined different fluorescent probes suitable for fluorometric determination of alpha 1-acid glycoprotein (AGP) in serum. Quinaldine red (QR) was shown to bind strongly and selectively to AGP. Taking advantage of the enhanced fluorescence of QR in the presence of AGP, we developed a direct method for the determination of serum AGP without removal of other serum proteins such as albumin. AGP concentrations in serum of healthy volunteers and patients correlated well with results from the conventional single radial immunodiffusion (SRID) method (r = 0.93, slope = 1). The newly developed method is faster and has a larger analytical concentration range than the SRID method. This method can also be used to determine AGP in serum of experimental animals, and it can serve to monitor AGP serum concentrations for pharmacokinetic evaluation of basic drugs.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8058617     DOI: 10.1023/a:1018926902083

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  13 in total

1.  Effects of inflammatory disease on plasma oxprenolol concentrations.

Authors:  M J Kendall; C P Quarterman; H Bishop; R E Schneider
Journal:  Br Med J       Date:  1979-08-25

Review 2.  Drug binding to human alpha-1-acid glycoprotein in health and disease.

Authors:  J M Kremer; J Wilting; L H Janssen
Journal:  Pharmacol Rev       Date:  1988-03       Impact factor: 25.468

3.  Homology and structure-function correlations between alpha 1-acid glycoprotein and serum retinol-binding protein and its relatives.

Authors:  S Pervaiz; K Brew
Journal:  FASEB J       Date:  1987-09       Impact factor: 5.191

4.  Evaluation of quinaldine red as a fluorescent probe for studies of drug-alpha 1-acid glycoprotein interaction.

Authors:  H Imamura; T Maruyama; M Otagiri
Journal:  Biol Pharm Bull       Date:  1993-09       Impact factor: 2.233

5.  An abnormal orosomucoid in the plasma of patients with neoplastic disease.

Authors:  D Rudman; P E Treadwell; W R Vogler; C H Howard; B Hollins
Journal:  Cancer Res       Date:  1972-09       Impact factor: 12.701

6.  Binding of beta-adrenoceptor blocking drugs to human serum albumin, to alpha 1-acid glycoprotein and to human serum.

Authors:  F M Belpaire; M G Bogaert; M Rosseneu
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

7.  Auramine O as a fluorescent probe for the binding of basic drugs to human alpha 1-acid glycoprotein (alpha 1-AG). The development of a simple fluorometric method for the determination of alpha 1-AG in human serum.

Authors:  Y Sugiyama; Y Suzuki; Y Sawada; S Kawasaki; T Beppu; T Iga; M Hanano
Journal:  Biochem Pharmacol       Date:  1985-03-15       Impact factor: 5.858

8.  Interaction of an acute phase reactant, alpha 1-acid glycoprotein (orosomucoid), with the lymphoid cell surface: a model for non-specific immune suppression.

Authors:  D A Cheresh; D H Haynes; J A Distasio
Journal:  Immunology       Date:  1984-03       Impact factor: 7.397

9.  Steroid-protein interactions. XIX. Complex formation between alpha 1-acid glycoprotein and steroid hormones.

Authors:  J Kerkay; U Westphal
Journal:  Biochim Biophys Acta       Date:  1968-12-23

10.  Effects of cancer and its treatments on plasma concentration of alpha 1-acid glycoprotein and propranolol binding.

Authors:  F P Abramson; J Jenkins; Y Ostchega
Journal:  Clin Pharmacol Ther       Date:  1982-11       Impact factor: 6.875

View more
  3 in total

1.  Development of a microcolumn one-site immunometric assay for a protein biomarker: Analysis of alpha1-acid glycoprotein.

Authors:  Chenhua Zhang; Shae Lott; William Clarke; David S Hage
Journal:  J Chromatogr A       Date:  2019-09-20       Impact factor: 4.759

2.  Altered disposition and effect of lerisetron in rats with elevated alpha 1-acid glycoprotein levels.

Authors:  N Jauregizar; R Calvo; E Suarez; A Quintana; E Raczka; J C Lukas
Journal:  Pharm Res       Date:  2001-06       Impact factor: 4.200

Review 3.  Alpha 1-acid glycoprotein (orosomucoid): pathophysiological changes in glycosylation in relation to its function.

Authors:  W van Dijk; E C Havenaar; E C Brinkman-van der Linden
Journal:  Glycoconj J       Date:  1995-06       Impact factor: 2.916

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.